Evidence map›Paper›PMID 7002186›Full record

ReviewBritish journal of clinical pharmacology1980

Kinetics and metabolism of paracetamol and phenacetin.

L F Prescott

2 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in British journal of clinical pharmacology, 1980. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 169 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03648658 phase4unknown statusnot on this mapstarted 2019, after this paper: background citation

Pharmacokinetics and Safety of Treatment With Paracetamol in Children and Adults With Spinal Muscular Atrophy and Cerebral Palsy

TypeinterventionalSponsorMette Cathrine OerngreenRan2019 to 2024Enrolled48ConditionsSMA II, Cerebral PalsyArmsParacetamol 120Mg/5mL Oral Suspension
NCT05685225 phase2withdrawnnot on this mapstarted 2025, after this paper: background citation

Safety and Efficacy of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Single-Site, Phase 2 Randomized Trial

TypeinterventionalSponsorAllodynic Therapeutics, IncRan2025 to 2025Enrolled0ConditionsMigraineArmsStage 1: Naltrexone/Acetaminophen, Stage 1: Naltrexone, Stage 1: Acetaminophen, Stage1: Placebo, Stage 2: Naltrxone/Acetaminophen high dose
3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 1 synthesis or guideline pooled it, 450 citations in OpenAlex.

  1. Interventions for paracetamol (acetaminophen) overdose.The Cochrane database of systematic reviews · 2018
    Pooled it
  2. Trial
  3. Caffeine, but not paracetamol (acetaminophen), enhances muscular endurance, strength, and power.Journal of the International Society of Sports Nutrition · 2024
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Trial
  11. Trial
  12. The effect of probenecid on paracetamol metabolism and pharmacokinetics.European journal of clinical pharmacology · 1993
    Trial
  13. A systems pharmacology model for paracetamol overdose and treatment.Journal of pharmacokinetics and pharmacodynamics · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

L F Prescott
Edinburgh Royal Infirmary · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

1 The rate of absorption of oral paracetamol depends on the rate of gastric emptying and is usually rapid and complete. The mean systemic availability is about 75%. 2 Paracetamol is extensively metabolized and the plasma half-life is 1.5-2.5 hours. About 55% and 30% of a therapeutic dose is excreted in the urine as glucuronide and sulphate conjugates, respectively, whereas mercapturic acid and cysteine conjugates (representing conversion to a potentially toxic intermediate metabolite) each account for some 4% of the dose. Paracetamol metabolism is age- and dose-dependent. 3 With hepatotoxic doses, paracetamol metabolism is impaired and the half-life prolonged. Sulphate conjugation is saturated and the proportion excreted as mercapturic acid and cysteine conjugates is increased. 4 The renal clearance of paracetamol depends on urine flow rate by not pH. The renal clearances of the glucuronide and sulphate conjugates often exceed the glomerular filtration rate and are independent of urine flow and pH. 5 Phenacetin absorption depends on formulation. It is extensively metabolized to paracetamol and minor metabolites are probably responsible for toxicity.

Indexed as

AcetaminophenAdministration, OralAdultAnimalsBiotransformationHumansIntestinal AbsorptionKineticsMetabolic Clearance RatePhenacetinTissue DistributionAcetaminophenPhenacetin

Identifiers

PMID7002186
PMCPMC1430174
OpenAlexW2008839228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.